Effects of co-administered ezetimibe and fenofibrate in mixed dyslipidaemic patients with metabolic syndrome

被引：0
|
作者：
Davies, M. J.
Bays, H. E.
Shah, A.
Macdonell, G.
Gumbiner, B.
机构：
[1] Merck & Co Inc, Rahway, NJ 07065 USA
[2] LMARC, Clin Res, Louisville, KY USA
来源：
DIABETOLOGIA | 2006年 / 49卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
0746
引用
收藏
页码：452 / 453
页数：2
相关论文
共 50 条
  • [41] The effects of laropiprant on the antiplatelet activity of co-administered clopidogrel and aspirin
    De Kam, Pieter-Jan
    Luo, Wen-Lin
    Wenning, Larissa
    Ratcliffe, Lisa
    Sisk, Christine McCrary
    Royalty, Jane
    Radziszewski, Waldemar
    Wagner, John A.
    Lai, Eseng
    PLATELETS, 2014, 25 (07) : 480 - 487
  • [42] Adiponectin and the anti-inflammatory effects of fenofibrate in patients with hypertriglyceridemia and the metabolic syndrome
    Rosenson, R. S.
    Huskin, A. L.
    Wolff, D. A.
    ATHEROSCLEROSIS SUPPLEMENTS, 2006, 7 (03) : 175 - 175
  • [43] Effects of ezetimibe on hypercholesterolemia in the lipid profile in patients with metabolic syndrome: Zenith Trial
    Kumagai, Naoko
    Miura, Shin-ichiro
    Zhang, Bo
    Noda, Keita
    Saku, Keijiro
    IJC METABOLIC & ENDOCRINE, 2013, 1 : 7 - 12
  • [44] Effect of Fenofibrate and Ezetimibe on lipoprotein subclasses and LDL subclass pattern in patients with mixed hyperlipidemia
    Tribble, D
    Farnier, M
    Freeman, MW
    Macdonell, G
    Perevozskaya, I
    Davies, MJ
    Gumbiner, B
    CIRCULATION, 2004, 110 (17) : 143 - 144
  • [45] Safety and efficacy of long-term coadministration of fenofibrate and ezetimibe in patients with mixed hyperlipidemia
    McKenney, JM
    Farnier, M
    Lo, KW
    Wan, C
    Perevozskaya, I
    Carlson, G
    Macdonell, G
    Davies, MJ
    Mitchel, Y
    Gumbiner, B
    CIRCULATION, 2005, 112 (17) : U266 - U266
  • [46] Effects of ezetimibe 5 mg versus ezetimibe 10 mg co-administered with simvastatin 10 mg on serum lipid, high-sensitivity C-reactive protein (hsCRP) and fibrinogen in patients with hypercholesterolemia
    Sansanayudh, N.
    Wongwiwatthananukit, S.
    Bumrungpruek, S.
    EUROPEAN HEART JOURNAL, 2008, 29 : 609 - 609
  • [47] Effects of co-administered extended release niacin/laropiprant and simvastatin on lipoprotein subclasses in patients with dyslipidemia
    Ballanlyne, Christie
    Gleim, Gilbert
    Mitchel, Yale
    Thompson-Bell, Sally
    Liu, Nancy
    Johnson-Levonas, Amy
    Paolini, John F.
    JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2008, 51 (10) : A325 - A326
  • [48] Food effects in paediatric medicines development for products Co-administered with food
    Batchelor, Hannah
    Kaukonen, Ann Marie
    Klein, Sandra
    Davit, Barbara
    Ju, Rob
    Ternik, Robert
    Heimbach, Tycho
    Lin, Wen
    Wang, Jian
    Storey, David
    INTERNATIONAL JOURNAL OF PHARMACEUTICS, 2018, 536 (02) : 530 - 535
  • [49] THE EFFECTS OF AGE AND RENAL IMPAIRMENT ON THE PHARMACOKINETICS OF CO-ADMINISTERED LISINOPRIL AND HYDROCHLOROTHIAZIDE
    LAHER, MSM
    MULKERRINS, E
    HOSIE, J
    CONNELL, PA
    SMITH, RP
    SWAISLAND, AJ
    JOURNAL OF HUMAN HYPERTENSION, 1991, 5 : 77 - 84
  • [50] Vascular and metabolic effects of fenofibrate in hypertriglyceridemic patients
    Koh, KK
    Han, SH
    Quon, MJ
    Kang, WC
    Shin, MS
    Shin, EK
    JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2005, 45 (03) : 428A - 428A
12345